$BMY: BRISTOL-MYERS SQUIBB COMPANY SAYS CORR 40.5% FOR IZA-BREN VS 20.2% FOR

$BMY

$BMY – BRISTOL-MYERS SQUIBB COMPANY SAYS CORR 40.5% FOR IZA-BREN VS 20.2% FOR CHEMOTHERAPY; MDOR 6.9 VS 4.2 MONTHS; IZA-BREN REDUCES RISK OF PROGRESSION OR DEATH BY 59% IN PHASE 3 BREAST…

2026-10-23 11:38:31 UTC · TELEGRAM · All $BMY

?? Positive AI Sentiment (+6.5 / 10)

BRISTOL-MYERS SQUIBB COMPANY SAYS CORR 40.5% FOR IZA-BREN VS 20.2% FOR CHEMOTHERAPY; MDOR 6.9 VS 4.2 MONTHS; IZA-BREN REDUCES RISK OF PROGRESSION OR DEATH BY 59% IN PHASE 3 BREAST CANCER STUDY ...

Observed market reaction after signal

4h -1.93% · 24h -2.41%